Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Hepion Pharmaceuticals, Inc. | 1,250,000 | reported | 21 Apr 2026 | tx 1+1,250,000 |
| Tharimmune, Inc. | 225,962 | reported | 03 Nov 2025 | tx 13+360,034−75,757 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Apr 2026 | PURCHASE | Hepion Pharmaceuticals, Inc. | 1,250,000 | 0.04 USD | |
| 03 Nov 2025 | GRANT_AWARD | Tharimmune, Inc. | 20,000 | 0.00 USD | deriv |
| 04 Aug 2025 | GRANT_AWARD | Tharimmune, Inc. | 90,000 | 0.00 USD | deriv |
| 20 Jun 2025 | PURCHASE | Tharimmune, Inc. | 690 | 1.42 USD | |
| 20 Jun 2025 | PURCHASE | Tharimmune, Inc. | 60,806 | 1.48 USD | |
| 13 Jan 2025 | GRANT_AWARD | Tharimmune, Inc. | 52,875 | 0.00 USD | deriv |
| 13 Nov 2024 | PURCHASE | Tharimmune, Inc. | 5,000 | 2.02 USD | |
| 08 Oct 2024 | PURCHASE | Tharimmune, Inc. | 5,000 | 1.93 USD | |
| 09 Aug 2024 | GRANT_AWARD | Tharimmune, Inc. | 38,087 | 0.00 USD | deriv |
| 07 Nov 2023 | GRANT_AWARD | Tharimmune, Inc. | 25,000 | 0.00 USD | deriv |
| 14 Jul 2022 | GIFT | Tharimmune, Inc. | 7,576 | 0.00 USD | |
| 14 Jul 2022 | GIFT | Tharimmune, Inc. | 75,757 | 0.00 USD | |
| 21 Mar 2022 | GRANT_AWARD | Tharimmune, Inc. | 50,000 | 0.00 USD | deriv |